Read about Pregnancy Research, Back to School and more

["FDA Office of Women's Health" <fda@xxxxxxxxxxxxxxxxxxxxxxx>]

Title: Read about Pregnancy Research, Back to School and more

FDA Office of Women's Health August e-Update

August 2017

www.fda.gov/womens

Message from the Director

FDA works to address the health issues impacting women across the lifespan. In this update you will find tips for young women leaving for college, resources to help women of all ages maintain eye health, and information on pregnancy research.

Enhancing the health of mothers and their babies is a priority for FDA. This month, I encourage you to learn about how FDA makes a difference in the lives of pregnant women. In a new blog, we outline some of the ways FDA is working to improve information on the medical products used by pregnant women. Please also visit our pregnancy webpage and share important safety information on FDA-regulated products with pregnant women in your family and community. Through scientific research and outreach, OWH continues to be a catalyst for promoting pregnancy initiatives. We look forward to working with our FDA colleagues and other partners on the Task Force on Research Specific to Pregnant Women and Lactating Women.

Marsha Henderson, Assistant Commissioner for Women's Health

WOMEN�S HEALTH HIGHLIGHTS

[New Blog] Working to Improve Information on Medication Use during Pregnancy

About half of the 6.3 million women who are pregnant every year take at least one medication, and prescription use is on the rise. FDA is continuing our work to help improve the information that doctors and pregnant women have available to support their healthcare decisions. Read our latest blog from OWH�s Deputy Director and Director of Research and Development, Dr. Pamela Scott, to learn more about FDA research and outreach to help keep pregnant women safe.

• Read �Working to Improve Information on Medication Use during Pregnancy.�
• Learn about OWH�s Pregnancy Research Initiatives�and OWH-Funded Pregnancy Research.
• Share consumer resources on medication use during pregnancy.

Back to Campus: Tips for College Women

Maintaining good health is a cornerstone for academic success. FDA has tips to help college women stay safe and healthy while away at college. Use these resources to help spread the word to young women about health topics including medication safety, sleep problems, tattoos and much more. Share these tips on your Twitter and Pinterest accounts.

• Link to FDA�s College Women�s Health webpage, www.fda.gov/collegewomen.�
• Read and share, �5 Health Tips College Women Need to Know� in your newsletter or blog.
• Download the College Women�s Social Media Toolkit and accompanying social media images.
• Order free fact sheets and posters to use in your campus outreach.

FDA provides new tools for the development and proper evaluation of tests for detecting Zika virus infection

As an additional measure in the fight against Zika virus, the U.S. Food and Drug Administration announced that it has made available a panel of human plasma samples to aid in the regulatory evaluation of serological tests to detect recent Zika virus infection.

Learn more about these new tools.

Patient Engagement Advisory Committee Meeting

On October 11 and 12, 2017, FDA will hold a public advisory committee meeting of the Patient Engagement Advisory Committee (PEAC) at the Hilton in Gaithersburg. The committee will discuss and make recommendations on the topic of patient input into medical device clinical trials. This meeting will provide the opportunity to bring patients, patient organizations, FDA, industry, and other medical and scientific experts together for a broader discussion on this important patient-related issue.

Learn more about the meeting.

Extras

Contacts Lens Health Week is August 21 � 25, 2017

Contact lenses help people improve vision, but they can be harmful if not used correctly. During Contact Lens Health Week, share tips from OWH to help women remember their eye health.

• Download and share the Contact Lens Care fact sheet in English and Spanish.
• Watch the Improper Use of Decorative Contacts video.
• Retweet contact lens care safety messages from @FDAWomen on Twitter.

FDA Grand Rounds

Tune in to FDA�s Grand Rounds, web cast live on Thursday, September 14 from 12 � 1 p.m. EST. Dr. David Strauss, Director of the Division of Applied Regulatory Science, will be presenting on developing a mechanistic model-based approach to assess cardiac safety of new drugs.

View the Meeting Webpage.

Healthy People 2030 Public Comment Period is now open!

The U.S. Department of Health and Human Services (HHS) is soliciting written comments on the proposed framework for Healthy People 2030 that was developed by the Secretary�s Advisory Committee on National Health Promotion and Disease Prevention Objectives for 2030 (Committee).

Members of the public are invited to submit comments on the proposed framework from June 27 through September 29, 2017.

Learn more and submit your comments today.

Meetings

Participate in upcoming FDA Public Meetings.

Enhanced Drug Distribution Security under the Drug Supply Chain Security Act

August 23, 2017, 9:00 am to 4:00 pm

FDA White Oak Campus, Silver Spring, MD

Pediatric Trial Design and Modeling: Moving into the Next Decade

September 8, 2017, 8:30 am to 4:30 pm

FDA White Oak Campus, Silver Spring, MD

Reducing the Risk of Preventable Adverse Drug Events associated with Hypoglycemia in the Older Population

September 12, 2017, 9:00 am to 4:00 pm

FDA White Oak Campus, Silver Spring, MD

Antimicrobial Susceptibility and Resistance: Addressing Challenges of Diagnostic Devices

September 12, 2017, 8:30 am to 5:00 pm

FDA White Oak Campus, Silver Spring, MD

Visit the OWH exhibit booth at these upcoming conferences.

U.S. Conference on AIDS

September 7 � 10, 2017, Washington, DC

American Academy of Family Physicians

September 12 � 16, 2017, San Antonio, TX

Learn more about OWH staff presentations at national and international meetings and conferences.

Please share this update with your network, members, constituents, and community.
FDA Office of Women's Health,�owh@xxxxxxx, 301�796�9440
10903 New Hampshire Avenue, WO32�Room 2333, Silver Spring, MD 20993

---

Subscriber Services:
Manage Preferences��|��Unsubscribe��|��Help with this service

---

This email was sent to list-fda@xxxxxxxxxxx using GovDelivery Communications Cloud on behalf of: U.S. Food & Drug Administration (FDA) � 10903 New Hampshire Ave � Silver Spring, MD 20993 � 1-888-INFO-FDA (1-888-463-6332)